164 related articles for article (PubMed ID: 11960906)
1. Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia.
Kuerbitz SJ; Pahys J; Wilson A; Compitello N; Gray TA
Carcinogenesis; 2002 Apr; 23(4):559-64. PubMed ID: 11960906
[TBL] [Abstract][Full Text] [Related]
2. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
3. The neuronatin gene resides in a "micro-imprinted" domain on human chromosome 20q11.2.
Evans HK; Wylie AA; Murphy SK; Jirtle RL
Genomics; 2001 Sep; 77(1-2):99-104. PubMed ID: 11543638
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.
Corn PG; Smith BD; Ruckdeschel ES; Douglas D; Baylin SB; Herman JG
Clin Cancer Res; 2000 Nov; 6(11):4243-8. PubMed ID: 11106238
[TBL] [Abstract][Full Text] [Related]
5. Selective methylation of CpGs at regulatory binding sites controls NNAT expression in Wilms tumors.
Hubertus J; Zitzmann F; Trippel F; Müller-Höcker J; Stehr M; von Schweinitz D; Kappler R
PLoS One; 2013; 8(6):e67605. PubMed ID: 23825673
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
[TBL] [Abstract][Full Text] [Related]
7. The putative Neuronatin imprint control region is an enhancer that also regulates the Blcap gene.
Thamban T; Sowpati DT; Pai V; Nithianandam V; Abe T; Shioi G; Mishra RK; Khosla S
Epigenomics; 2019 Feb; 11(3):251-266. PubMed ID: 30672333
[TBL] [Abstract][Full Text] [Related]
8. Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity.
Yu V; Yong F; Marta A; Khadayate S; Osakwe A; Bhattacharya S; Varghese SS; Chabosseau P; Tabibi SM; Chen K; Georgiadou E; Parveen N; Suleiman M; Stamoulis Z; Marselli L; De Luca C; Tesi M; Ostinelli G; Delgadillo-Silva L; Wu X; Hatanaka Y; Montoya A; Elliott J; Patel B; Demchenko N; Whilding C; Hajkova P; Shliaha P; Kramer H; Ali Y; Marchetti P; Sladek R; Dhawan S; Withers DJ; Rutter GA; Millership SJ
Diabetologia; 2024 Jun; 67(6):1079-1094. PubMed ID: 38512414
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice.
Wolff L; Garin MT; Koller R; Bies J; Liao W; Malumbres M; Tessarollo L; Powell D; Perella C
Oncogene; 2003 Dec; 22(58):9265-74. PubMed ID: 14681685
[TBL] [Abstract][Full Text] [Related]
10. Genetic and functional analysis of neuronatin in mice with maternal or paternal duplication of distal Chr 2.
Kikyo N; Williamson CM; John RM; Barton SC; Beechey CV; Ball ST; Cattanach BM; Surani MA; Peters J
Dev Biol; 1997 Oct; 190(1):66-77. PubMed ID: 9331332
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-mediated silencing of neuronatin (NNAT) in pig parthenogenetic fetuses.
Chen X; Wang T; Lv Q; Wang A; Ouyang H; Li Z
Gene; 2014 Nov; 552(1):204-8. PubMed ID: 25240791
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.
Dunwell TL; Dickinson RE; Stankovic T; Dallol A; Weston V; Austen B; Catchpoole D; Maher ER; Latif F
Epigenetics; 2009 May; 4(4):265-9. PubMed ID: 19550140
[TBL] [Abstract][Full Text] [Related]
15. Aberrant epigenetic silencing of neuronatin is a frequent event in human osteosarcoma.
Saeed H; Sinha S; Mella C; Kuerbitz JS; Cales ML; Steele MA; Stanke J; Damron D; Safadi F; Kuerbitz SJ
Oncotarget; 2020 May; 11(20):1876-1893. PubMed ID: 32499872
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman JG; Jen J; Merlo A; Baylin SB
Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
19. Imprinted expression of neuronatin from modified BAC transgenes reveals regulation by distinct and distant enhancers.
John RM; Aparicio SA; Ainscough JF; Arney KL; Khosla S; Hawker K; Hilton KJ; Barton SC; Surani MA
Dev Biol; 2001 Aug; 236(2):387-99. PubMed ID: 11476579
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
